REPORT ID 2683

Global Non-Invasive Blood Glucose Monitoring Devices Market Research Report 2018

Publish Date
2018
Pages
116
Format
Electronic (PDF)

The global Non-Invasive Blood Glucose Monitoring Devices market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025. The objectives of this study are to define, segment, and project the size of the Non-Invasive Blood Glucose Monitoring Devices market based on company, product type, end user and key regions.
This report studies the global market size of Non-Invasive Blood Glucose Monitoring Devices in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Non-Invasive Blood Glucose Monitoring Devices in these regions.

This research report categorizes the global Non-Invasive Blood Glucose Monitoring Devices market by top players/brands, region, type and end user. This report also studies the global Non-Invasive Blood Glucose Monitoring Devices market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

    Abbott

    BD Medical

    Medtronic

    Sanofi

    Roche Diagnostics

    Animas Technologies

    Bayer Healthcare

    Cercacor

    Pendragon Medical

    OrSense

    Nova Biomedical

    Dexcom

    Terumo

    Tosoh Bioscience

Market size by Product

    MIR/NIR (Mid/Near Infrared Spectroscopy)

    Raman Spectroscopy

    Occlusion Spectroscopy

    Optical Coherence Tomography

    Photoacoustic Spectroscopy

    Electromagnetic

    Fluorescence

    Other

Market size by End User

    Hospitals

    Clinics

    Home Care Settings

    Other

Market size by Region

    North America

        United States

        Canada

        Mexico

    Asia-Pacific

        China

        India

        Japan

        South Korea

        Australia

        Indonesia

        Singapore

        Malaysia

        Philippines

        Thailand

        Vietnam

    Europe

        Germany

        France

        UK

        Italy

        Spain

        Russia

    Central & South America

        Brazil

        Rest of Central & South America

    Middle East & Africa

        GCC Countries

        Turkey

        Egypt

        South Africa

The study objectives of this report are:

    To study and analyze the global Non-Invasive Blood Glucose Monitoring Devices market size (value & volume) by company, key regions, products and end user, breakdown data from 2013 to 2017, and forecast to 2025.

    To understand the structure of Non-Invasive Blood Glucose Monitoring Devices market by identifying its various subsegments.

    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

    Focuses on the key global Non-Invasive Blood Glucose Monitoring Devices companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

    To project the value and sales volume of Non-Invasive Blood Glucose Monitoring Devices submarkets, with respect to key regions.

    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Non-Invasive Blood Glucose Monitoring Devices are as follows:

    History Year: 2013-2017

    Base Year: 2017

    Estimated Year: 2018

    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Non-Invasive Blood Glucose Monitoring Devices market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered. 
			   
Table of Contents
1 Study Coverage

    1.1 Non-Invasive Blood Glucose Monitoring Devices Product

    1.2 Market Segments

    1.3 Key Manufacturers Covered

    1.4 Market by Type

        1.4.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Growth Rate by Product

        1.4.2 MIR/NIR (Mid/Near Infrared Spectroscopy)

        1.4.3 Raman Spectroscopy

        1.4.4 Occlusion Spectroscopy

        1.4.5 Optical Coherence Tomography

        1.4.6 Photoacoustic Spectroscopy

        1.4.7 Electromagnetic

        1.4.8 Fluorescence

        1.4.9 Other

    1.5 Market by End User

        1.5.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size Growth Rate by End User

        1.5.2 Hospitals

        1.5.3 Clinics

        1.5.4 Home Care Settings

        1.5.5 Other

    1.6 Study Objectives

    1.7 Years Considered

2 Executive Summary

    2.1 Global Non-Invasive Blood Glucose Monitoring Devices Market Size

        2.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Revenue 2013-2025

        2.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Sales 2013-2025

    2.2 Non-Invasive Blood Glucose Monitoring Devices Growth Rate by Regions

        2.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Regions

        2.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Regions

3 Breakdown Data by Manufacturers

    3.1 Non-Invasive Blood Glucose Monitoring Devices Sales by Manufacturers

        3.1.1 Non-Invasive Blood Glucose Monitoring Devices Sales by Manufacturers

        3.1.2 Non-Invasive Blood Glucose Monitoring Devices Sales Market Share by Manufacturers

        3.1.3 Global Non-Invasive Blood Glucose Monitoring Devices Market Concentration Ratio (CR5 and HHI)

    3.2 Non-Invasive Blood Glucose Monitoring Devices Revenue by Manufacturers

        3.2.1 Non-Invasive Blood Glucose Monitoring Devices Revenue by Manufacturers (2013-2018)

        3.2.2 Non-Invasive Blood Glucose Monitoring Devices Revenue Share by Manufacturers (2013-2018)

    3.3 Non-Invasive Blood Glucose Monitoring Devices Price by Manufacturers

    3.4 Non-Invasive Blood Glucose Monitoring Devices Manufacturing Base Distribution, Product Types

        3.4.1 Non-Invasive Blood Glucose Monitoring Devices Manufacturers Manufacturing Base Distribution, Headquarters

        3.4.2 Manufacturers Non-Invasive Blood Glucose Monitoring Devices Product Type

        3.4.3 Date of International Manufacturers Enter into Non-Invasive Blood Glucose Monitoring Devices Market

    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

    4.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales by Product

    4.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue by Product

    4.3 Non-Invasive Blood Glucose Monitoring Devices Price by Product

5 Breakdown Data by End User

    5.1 Overview

    5.2 Global Non-Invasive Blood Glucose Monitoring Devices Breakdown Data by End User

6 North America

    6.1 North America Non-Invasive Blood Glucose Monitoring Devices by Countries

        6.1.1 North America Non-Invasive Blood Glucose Monitoring Devices Sales by Countries

        6.1.2 North America Non-Invasive Blood Glucose Monitoring Devices Revenue by Countries

        6.1.3 United States

        6.1.4 Canada

        6.1.5 Mexico

    6.2 North America Non-Invasive Blood Glucose Monitoring Devices by Product

    6.3 North America Non-Invasive Blood Glucose Monitoring Devices by End User

7 Europe

    7.1 Europe Non-Invasive Blood Glucose Monitoring Devices by Countries

        7.1.1 Europe Non-Invasive Blood Glucose Monitoring Devices Sales by Countries

        7.1.2 Europe Non-Invasive Blood Glucose Monitoring Devices Revenue by Countries

        7.1.3 Germany

        7.1.4 France

        7.1.5 UK

        7.1.6 Italy

        7.1.7 Russia

    7.2 Europe Non-Invasive Blood Glucose Monitoring Devices by Product

    7.3 Europe Non-Invasive Blood Glucose Monitoring Devices by End User

8 Asia Pacific

    8.1 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices by Countries

        8.1.1 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Sales by Countries

        8.1.2 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Revenue by Countries

        8.1.3 China

        8.1.4 Japan

        8.1.5 Korea

        8.1.6 India

        8.1.7 Australia

        8.1.8 Indonesia

        8.1.9 Malaysia

        8.1.10 Philippines

        8.1.11 Thailand

        8.1.12 Vietnam

        8.1.13 Singapore

    8.2 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices by Product

    8.3 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices by End User

9 Central & South America

    9.1 Central & South America Non-Invasive Blood Glucose Monitoring Devices by Countries

        9.1.1 Central & South America Non-Invasive Blood Glucose Monitoring Devices Sales by Countries

        9.1.2 Central & South America Non-Invasive Blood Glucose Monitoring Devices Revenue by Countries

        9.1.3 Brazil

    9.2 Central & South America Non-Invasive Blood Glucose Monitoring Devices by Product

    9.3 Central & South America Non-Invasive Blood Glucose Monitoring Devices by End User

10 Middle East and Africa

    10.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices by Countries

        10.1.1 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Sales by Countries

        10.1.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Revenue by Countries

        10.1.3 GCC Countries

        10.1.4 Turkey

        10.1.5 Egypt

        10.1.6 South Africa

    10.2 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices by Product

    10.3 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices by End User

11 Company Profiles

    11.1 Abbott

        11.1.1 Abbott Company Details

        11.1.2 Company Business Overview

        11.1.3 Abbott Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.1.4 Abbott Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.1.5 Abbott Recent Development

    11.2 BD Medical

        11.2.1 BD Medical Company Details

        11.2.2 Company Business Overview

        11.2.3 BD Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.2.4 BD Medical Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.2.5 BD Medical Recent Development

    11.3 Medtronic

        11.3.1 Medtronic Company Details

        11.3.2 Company Business Overview

        11.3.Medtronic Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.3.4 Medtronic Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.3.5 Medtronic Recent Development

    11.4 Sanofi

        11.4.1 Sanofi Company Details

        11.4.2 Company Business Overview

        11.4.3 Sanofi Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.4.4 Sanofi Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.4.5 Sanofi Recent Development

    11.5 Roche Diagnostics

        11.5.1 Roche Diagnostics Company Details

        11.5.2 Company Business Overview

        11.5.3 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.5.4 Roche Diagnostics Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.5.5 Roche Diagnostics Recent Development

    11.6 Animas Technologies

        11.6.1 Animas Technologies Company Details

        11.6.2 Company Business Overview

        11.6.3 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.6.4 Animas Technologies Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.6.5 Animas Technologies Recent Development

    11.7 Bayer Healthcare

        11.7.1 Bayer Healthcare Company Details

        11.7.2 Company Business Overview

        11.7.3 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.7.4 Bayer Healthcare Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.7.5 Bayer Healthcare Recent Development

    11.8 Cercacor

        11.8.1 Cercacor Company Details

        11.8.2 Company Business Overview

        11.8.3 Cercacor Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.8.4 Cercacor Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.8.5 Cercacor Recent Development

    11.9 Pendragon Medical

        11.9.1 Pendragon Medical Company Details

        11.9.2 Company Business Overview

        11.9.3 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.9.4 Pendragon Medical Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.9.5 Pendragon Medical Recent Development

    11.10 OrSense

        11.10.1 OrSense Company Details

        11.10.2 Company Business Overview

        11.10.3 OrSense Non-Invasive Blood Glucose Monitoring Devices Sales, Revenue and Gross Margin (2013-2018)

        11.10.4 OrSense Non-Invasive Blood Glucose Monitoring Devices Products Offered

        11.10.5 OrSense Recent Development

    11.11 Nova Biomedical

    11.12 Dexcom

    11.13 Terumo

    11.14 Tosoh Bioscience

12 Future Forecast

    12.1 Non-Invasive Blood Glucose Monitoring Devices Market Forecast by Regions

        12.1.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Regions 2018-2025

        12.1.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Forecast by Regions 2018-2025

    12.2 Non-Invasive Blood Glucose Monitoring Devices Market Forecast by Product

        12.2.1 Global Non-Invasive Blood Glucose Monitoring Devices Sales Forecast by Product 2018-2025

        12.2.2 Global Non-Invasive Blood Glucose Monitoring Devices Revenue Forecast by Product 2018-2025

    12.3 Non-Invasive Blood Glucose Monitoring Devices Market Forecast by End User

    12.4 North America Non-Invasive Blood Glucose Monitoring Devices Forecast

    12.5 Europe Non-Invasive Blood Glucose Monitoring Devices Forecast

    12.6 Asia Pacific Non-Invasive Blood Glucose Monitoring Devices Forecast

    12.7 Central & South America Non-Invasive Blood Glucose Monitoring Devices Forecast

    12.8 Middle East and Africa Non-Invasive Blood Glucose Monitoring Devices Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

    13.1 Market Opportunities and Drivers

    13.2 Market Challenges

    13.3 Market Risks/Restraints

    13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

    14.1 Value Chain Analysis

    14.2 Non-Invasive Blood Glucose Monitoring Devices Customers

    14.3 Sales Channels Analysis

        14.3.1 Sales Channels

        14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

    16.1 Research Methodology

        16.1.1 Methodology/Research Approach

        16.1.2 Data Source

    16.2 Author Details

    16.3 Disclaimer